Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc
about
Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc
description
article publié dans la revue scientifique PLoS ONE
@fr
im Januar 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in PLoS ONE
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2018
@uk
name
Phase I trial of pod-intravagi ...... , emtricitabine, and maraviroc
@en
Phase I trial of pod-intravagi ...... , emtricitabine, and maraviroc
@nl
type
label
Phase I trial of pod-intravagi ...... , emtricitabine, and maraviroc
@en
Phase I trial of pod-intravagi ...... , emtricitabine, and maraviroc
@nl
prefLabel
Phase I trial of pod-intravagi ...... , emtricitabine, and maraviroc
@en
Phase I trial of pod-intravagi ...... , emtricitabine, and maraviroc
@nl
P2093
P2860
P50
P1433
P1476
Phase I trial of pod-intravagi ...... , emtricitabine, and maraviroc
@en
P2093
John A Moss
Lauren N Dawson
Manjula Gunawardana
Trevelyn J Olive
P2860
P304
P356
10.1371/JOURNAL.PONE.0201952
P407
P577
2018-08-22T00:00:00Z